-+ 0.00%
-+ 0.00%
-+ 0.00%

SKYE BIOSCIENCE INC: SKYE IS PLANNING TO INITIATE A PHASE 2B CLINICAL TRIAL IN OBESITY FOR NIMACIMAB WITH ENHANZE IN MIDDLE OF 2026

Reuters·01/05/2026 12:00:18

Please log in to view news